This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SPEAR, J. F. Articles by GERSTENBLITH, G. Search for Related Content PubMed PubMed Citation Articles by SPEAR, J. F. Articles by GERSTENBLITH, G.

(Circulation. 1972;46:65.)
© 1972 American Heart Association, Inc.

---

Effect of Lidocaine on the Ventricular Fibrillation Threshold in the Dog during Acute Ischemia and Premature Ventricular Contractions

JOSEPH F. SPEAR PH.D.¹; E. NEIL MOORE D.V.M., PH.D.¹; GAIRY GERSTENBLITH M.D.¹

¹ From the Comparative Cardiovascular Studies Unit, Department of Animal Biology, School of Veterinary Medicine, and the Hospital of the University of Pennsylvania, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

The effect of lidocaine on the ventricular fibrillation threshold was investigated in the anesthetized open-chest dog during paced supraventricular rhythm, during acute ligation of the anterior descending coronary artery, and during premature ventricular contractions. The minimum current (in milliamperes) required to induce ventricular fibrillation was determined by passing a train (100 Hz) of 10-14 constant-current pulses through ventricular epicardial electrodes during the vulnerable period of the cardiac cycle. Lidocaine was administered intravenously either as a sudden injection or as a "loading" injection followed by a constant infusion. Following a single injection of 0.7 mg/kg the blood lidocaine decreased to half its original arterial concentration in 9 min. After the termination of a 50-60-min constant drip of 70 µg/kg/min which was preceded by a loading injection of 2 mg/kg, the blood lidocaine concentration fell to 50% of its original value in 31 min. Lidocaine at therapeutic blood levels (1.2-5.5 µg/ml) increased the fibrillation threshold during paced supraventricular rhythm and reversed the fall in fibrillation threshold accompanying acute myocardial ischemia and premature ventricular contractions. The present studies quantify the ability of lidocaine to reduce the vulnerability of the heart to fibrillation during supraventricular rhythm, acute ischemia, and premature ventricular beats and provide information concerning the metabolism of lidocaine in the anesthetized dog.

Key Words: Ischemia • Vulnerability • Antiarrhythmia agent • Myocardial infarction • Sudden cardiac death • Defibrillation

Submitted on October 25, 1971
Accepted on January 27, 1972

This article has been cited by other articles:

				Part 7.2: Management of Cardiac Arrest Circulation, December 13, 2005; 112(24_suppl): IV-58 - IV-66. [Full Text] [PDF]